Fluticasone furoate
Systematic (IUPAC) name | |
---|---|
(6α,11β,16α,17α)-6,9-difluoro-17-{[(fluoro-methyl)thio]carbonyl}-11-hydroxy-16-methyl-3-oxoandrosta-1,4-dien-17-yl 2-furancarboxylate | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Pregnancy category |
|
Routes of administration | Intranasal |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 0.51% (Intranasal) |
Protein binding | 91% |
Metabolism |
Intranasal Hepatic (CYP3A4-mediated) |
Biological half-life | 10 hours |
Excretion | Renal |
Identifiers | |
CAS Number | 80474-14-2 |
ATC code | R01AD12 (WHO) R03BA09 |
PubChem | CID 9854489 |
DrugBank | DB00588 |
ChemSpider | 8030195 |
UNII | JS86977WNV |
ChEBI | CHEBI:74899 |
ChEMBL | CHEMBL1676 |
Chemical data | |
Formula | C27H29F3O6S |
Molar mass | 538.576 g/mol |
| |
|
Fluticasone furoate is a synthetic corticosteroid derived from fluticasone, marketed by GlaxoSmithKline as Veramyst (US) and Avamys (Australia, Canada, EU, South Africa, South America, Mexico, Israel, and South Korea) for the treatment of allergic rhinitis. It is marketed under the name Furamist in India by Cipla. In India it is also marketed by Dr Reddys under the trade name Ennhale. It can be administered by a nasal spray.[1]
The combination drug fluticasone furoate/vilanterol is approved for use in the United States by the Food and Drug Administration for long-term maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and emphysema.[2]
See also
References
- ↑ Bruni FM, De Luca G, Venturoli V, Boner AL (2009). "Intranasal corticosteroids and adrenal suppression". Neuroimmunomodulation 16 (5): 353–62. doi:10.1159/000216193. PMID 19571596.
- ↑ "FDA approves Breo Ellipta to treat chronic obstructive pulmonary disease". Food and Drug Administration. May 10, 2013.
|
|
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.